MODIFICATION TO TRIAGE B-TYPE NATRIURETIC PEPTIDE (BNP) TEST— 510(k) K032235

Substantially Equivalent

Biosite Incorporated

FDA 510(k) clearance K032235 for MODIFICATION TO TRIAGE B-TYPE NATRIURETIC PEPTIDE (BNP) TEST, Substantially Equivalent on 2004-01-28. Applicant: Biosite Incorporated.

Clearance details

Applicant: Biosite Incorporated
Product code: Code NBC
Advisory panel: Clinical Chemistry
Date received: 2003-07-21
Decision date: 2004-01-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.